The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma
Surgery Today · 2026-07 · 56 (7) · 1369-1374
DOI: 10.1007/s00595-026-03247-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 09.02.2026. Verfasst von Yoriko Nomura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama C…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, alpha-Fetoproteins, Prothrombin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortalities. Although hepatic resection provides favorable outcomes for resectable HCC (R-HCC), its recurrence rate remains high. This study aimed to evaluate the prognostic significance and clinical applicability of the Mac-2 binding protein glycosylation isomer (M2BPGi), lectin-reactive α-fetoprotein fraction (AFP-L3), and protein induced by vitamin K absence-II (PIVKA-II), together with tumor characteristics, in patients with R-HCC who underwent hepatic resection. METHODS: We retrospectively analyzed 250 R-HCC patients who underwent hepatic resection between 2015 and 2025 at a single institution. Preoperative biomarkers including M2BPGi, AFP-L3, and PIVKA-II, were evaluated. The primary endpoint was the disease-free survival (DFS). RESULTS: A multivariate analysis identified M2BPGi ≥ 1.0 (hazard ratio (HR) 2.01, p < 0.001), AFP-L3 ≥ 15% (HR, 1.84, p = 0.03), and PIVKA-II ≥ 500 mAU/mL (HR 2.44, p < 0.001) were independent predictors of recurrence. A scoring system based on the number of positive biomarkers significantly stratified DFS (P < 0.001). Patients positive for all three markers had the poorest prognoses. CONCLUSIONS: M2BPGi, AFP-L3, and PIVKA-II are independent risk factors for recurrent HCC. A simple biomarker-based scoring system offers practical guidance to hepatobiliary surgeons for tailoring postoperative surveillance and evaluating candidates for adjuvant strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama Chuo-ku, Fukuoka, 810-8563, Japan. yorikonomura25@gmail.com.
- Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama Chuo-ku, Fukuoka, 810-8563, Japan.
Zitieren
APA
Nomura, Y., Harimoto, N., Hashimoto, K., & Takeishi, K. (2026). The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma. Surgery Today, 56(7), 1369-1374. https://doi.org/10.1007/s00595-026-03247-7
Vancouver
Nomura Y, Harimoto N, Hashimoto K, Takeishi K. The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma. Surgery Today. 2026;56(7):1369-1374. doi:10.1007/s00595-026-03247-7
BibTeX
@article{Nomura2026,
author = {Nomura, Yoriko and Harimoto, Norifumi and Hashimoto, Kazuaki and Takeishi, Kazuki},
title = {The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive α-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {7},
pages = {1369--1374},
doi = {10.1007/s00595-026-03247-7}
}
EUVIMED